Quality Assurance

QUALITY ASSURANCE

The second-phase project has a total investment of 40 million yuan (including 8 million yuan in working capital), occupies an area of 52,905 square meters, and features a total building footprint of 24,938 square meters—of which 17,049 square meters are dedicated to production workshops and storage facilities. Currently, the company has obtained both the **Veterinary Drug Production License** (License No.: (2022) Veterinary Drug Prod. Cert. No. 22151, covering production scopes such as granules made from traditional Chinese medicine extracts, as well as specific extracts like Scutellaria baicalensis extract, Andrographis paniculata lactone, Artemisia capillaris extract, Licorice Extract, Forsythia suspensa extract, Patchouli Oil, and Berberine Hydrochloride) and the **Veterinary Drug GMP Certificate** (Certificate No.: (2022) Veterinary Drug GMP Cert. No. 22015). To date, the company has secured approval numbers for 20 distinct veterinary drug products, including Scutellaria baicalensis extract, Andrographis paniculata lactone, Artemisia capillaris extract, Patchouli Oil, Licorice Extract, Forsythia suspensa extract, Berberine Hydrochloride, Banqing Granules, Jinhuanglianban Granules, Maxing Shigan Granules, Sanwei Kangqiu Granules, Sihuang Zhili Granules, Yinzhi Jiedu Granules, Gan Dan Granules, Licorice Granules, Jiebai Granules, Qiqing Baidu Granules, Qizhen Zengmian Granules, Wuwei Changqing Granules, and Shuanghuang Baidu Granules.

Phase II Project

2025-10-24

Project Overview: Multi-functional Extraction Production Line Design Capacity: 150 tons of traditional Chinese medicine extracts annually Annual Output Value: 250 million


undefined

undefined